Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims.
Neurofenix has raised $6.9M in total funding. The most recent round was Series A. The last funding was announced in August 2022.
Neurofenix's investors include Entrepreneurs First, AlbionVC, Social Tech Trust, O2h Ventures, InHealth Ventures.
Neurofenix is headquartered in London, United Kingdom.
Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims.
Neurofenix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurofenix — Funding & Investors." VCBacked, August 29, 2022, https://www.vcbacked.co/company/neurofenix. Accessed November 11, 2026.
VCBacked. (2022). Neurofenix — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/neurofenix
{{cite web |title=Neurofenix — Funding & Investors |url=https://www.vcbacked.co/company/neurofenix |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Neurofenix? Request a listing update